266 results on '"Wang, Zi‐Xian"'
Search Results
2. Combined anti-PD-1, HDAC inhibitor and anti-VEGF for MSS/pMMR colorectal cancer: a randomized phase 2 trial
3. Perioperative toripalimab and chemotherapy in locally advanced gastric or gastro-esophageal junction cancer: a randomized phase 2 trial
4. Chemo-immunotherapy in advanced esophageal squamous cell carcinoma: present and future
5. Modulator of TMB-associated immune infiltration (MOTIF) predicts immunotherapy response and guides combination therapy
6. Delayed treatment effect predicting (DTEP) model for guiding immuno-oncology trial designs
7. First-line serplulimab in metastatic colorectal cancer: Phase 2 results of a randomized, double-blind, phase 2/3 trial
8. Author Correction: Perioperative toripalimab and chemotherapy in locally advanced gastric or gastro-esophageal junction cancer: a randomized phase 2 trial
9. Comprehensive genomic characterization of sporadic synchronous colorectal cancer: Implications for treatment optimization and clinical outcome
10. Irpex lacteus polysaccharide exhibits therapeutic potential for ovarian fibrosis in PCOS rats via the TGF-β1/smad pathway
11. Targeting the cholesterol-RORα/γ axis inhibits colorectal cancer progression through degrading c-myc
12. An immunogenic and oncogenic feature-based classification for chemotherapy plus PD-1 blockade in advanced esophageal squamous cell carcinoma
13. Arginine methylation of MTHFD1 by PRMT5 enhances anoikis resistance and cancer metastasis
14. 3D RoI-aware U-Net for Accurate and Efficient Colorectal Tumor Segmentation
15. Integrated analysis of single-cell and bulk RNA sequencing data reveals a pan-cancer stemness signature predicting immunotherapy response
16. Comprehensive profiling of 1015 patients’ exomes reveals genomic-clinical associations in colorectal cancer
17. Temporal Change in Treatment Patterns of Metastatic Colorectal Cancer and Its Association with Patient Survival: A Retrospective Cohort Study Based on an Intelligent Big-Data Platform
18. Sinapic acid modulates oxidative stress and metabolic disturbances to attenuate ovarian fibrosis in letrozole‐induced polycystic ovary syndrome SD rats.
19. Sinapic Acid Attenuates Chronic DSS-Induced Intestinal Fibrosis in C57BL/6J Mice by Modulating NLRP3 Inflammasome Activation and the Autophagy Pathway
20. EPHA7 mutation as a predictive biomarker for immune checkpoint inhibitors in multiple cancers
21. Association between cigarette smoking and colorectal cancer sidedness: A multi-center big-data platform-based analysis
22. Sinapic Acid Attenuates Chronic DSS-Induced Intestinal Fibrosis in C57BL/6J Mice by Modulating NLRP3 Inflammasome Activation and the Autophagy Pathway.
23. Long noncoding RNA Regulating ImMune Escape regulates mixed lineage leukaemia protein‐1‐H3K4me3‐mediated immune escape in oesophageal squamous cell carcinoma
24. CPT1A-mediated fatty acid oxidation promotes colorectal cancer cell metastasis by inhibiting anoikis
25. Immunotherapy in gastrointestinal cancers: advances, challenges, and countermeasures
26. Identification of cross-talk between m6A and 5mC regulators associated with onco-immunogenic features and prognosis across 33 cancer types
27. Alteration in TET1 as potential biomarker for immune checkpoint blockade in multiple cancers
28. Figure S1, Figure S2, Table S1, Table S2. from Submucosal Saline Injection Followed by Endoscopic Ultrasound versus Endoscopic Ultrasound Only for Distinguishing between T1a and T1b Esophageal Cancer
29. Reply to G. Yu et al
30. Clinical Benefit of First-Line Programmed Death-1 Antibody Plus Chemotherapy in Low Programmed Cell Death Ligand 1–Expressing Esophageal Squamous Cell Carcinoma: A Post Hoc Analysis of JUPITER-06 and Meta-Analysis
31. Impact of prior chemotherapy with two different fluoropyrimidines on the efficacy of capecitabine plus irinotecan or FOLFIRI with or without bevacizumab in metastatic colorectal cancer: a post hoc analysis of the AXEPT study
32. Designing gene panels for tumor mutational burden estimation: the need to shift from ‘correlation’ to ‘accuracy’
33. Comparative safety and efficacy of anti-PD-1 monotherapy, chemotherapy alone, and their combination therapy in advanced nasopharyngeal carcinoma: findings from recent advances in landmark trials
34. Phase I study of high-dose ascorbic acid with mFOLFOX6 or FOLFIRI in patients with metastatic colorectal cancer or gastric cancer
35. A phase Ib/II study of fruquintinib in combination with paclitaxel as the second‐line therapy for advanced gastric cancer
36. Phase II trial of S-1 plus leucovorin in patients with advanced gastric cancer and clinical prediction by S-1 pharmacogenetic pathway
37. Mutational profiles of sporadic synchronous colorectal cancer.
38. A multiple centers real-world study of regorafenib treatment modalities in Chinese metastatic colorectal cancer patients.
39. Additional file 1 of Integrated analysis of single-cell and bulk RNA sequencing data reveals a pan-cancer stemness signature predicting immunotherapy response
40. A phase Ib/II study of fruquintinib in combination with paclitaxel as the second‐line therapy for advanced gastric cancer.
41. Nutrition support can bring survival benefit to high nutrition risk gastric cancer patients who received chemotherapy
42. Toripalimab plus chemotherapy in treatment-naïve, advanced esophageal squamous cell carcinoma (JUPITER-06): A multi-center phase 3 trial
43. Impact of mismatch repair or microsatellite status on the prognosis and efficacy to chemotherapy in metastatic colorectal cancer patients: A bi-institutional, propensity score-matched study
44. 3-D RoI-Aware U-Net for Accurate and Efficient Colorectal Tumor Segmentation
45. Elevated peripheral blood neutrophil-to-lymphocyte ratio is associated with an immunosuppressive tumour microenvironment and decreased benefit of PD-1 antibody in advanced gastric cancer
46. Flaw Characterization and Sizing Using Sensitivity Analysis and the Boundary Element Method
47. Genomic temporal heterogeneity of circulating tumour DNA in unresectable metastatic colorectal cancer under first-line treatment
48. POLE/POLD1 mutation in non‐exonuclease domain matters for predicting efficacy of immune‐checkpoint‐inhibitor therapy
49. Free Triiodothyronine Connected With Metabolic Changes in Patients With Coronary Artery Disease by Interacting With Other Functional Indicators
50. Performance of common genetic variants in risk prediction for colorectal cancer in Chinese: A two-stage and multicenter study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.